Biogen
is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe... Read moreBiogen
is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe... Read more
News
Partnership
Feb 21, 2025
Global Legal Chronicle
Stoke Therapeutics' Collaboration with BioGen
Funding
Feb 12, 2025
MedicalMarketing& Media
Biogen received $250M in Post-IPO Equity Funding
Leadership Change
Jan 28, 2025
Biogen
Adam Feire joined Biogen as Head of Business Development and External Innovation
Layoffs
Jan 23, 2025
The Business Journals: Boston
Biogen lays off researchers, focuses on 'external collaborations'
Conference Presentation
Oct 24, 2024
FinanzNachrichten
Biogen Inc.: Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference
investment
Jul 23, 2024
https://www.businesswire.com/news/home/20240724394303/en/Autobahn-Therapeutics-Completes-Oversubscribed-100-Million-Series-C-Financing-to-Advance-Pipeline-of-Novel-Therapeutics-for-Depression-and-Other-CNS-Disorders/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT
Biogen, Inc. has invested $100M in Autobahn Therapeutics, Inc.
Acquisition
May 22, 2024
Benzinga
Biogen acquired Human Immunology Biosciences, Inc. for $1.1B
Biogen Competitors
1
2
3
4
5
6
7
8
9
10